Literature DB >> 22624835

Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla.

Jayanth R Arnold1, Theodoros D Karamitsos, Paul Bhamra-Ariza, Jane M Francis, Nick Searle, Matthew D Robson, Ruairidh K Howells, Robin P Choudhury, Ornella E Rimoldi, Paolo G Camici, Adrian P Banning, Stefan Neubauer, Michael Jerosch-Herold, Joseph B Selvanayagam.   

Abstract

OBJECTIVES: The purpose of this study was to assess the diagnostic accuracy of blood oxygen-level dependent (BOLD) MRI in suspected coronary artery disease (CAD).
BACKGROUND: By exploiting the paramagnetic properties of deoxyhemoglobin, BOLD magnetic resonance imaging can detect myocardial ischemia. We applied BOLD imaging and first-pass perfusion techniques to: 1) examine the pathophysiological relationship between coronary stenosis, perfusion, ventricular scar, and myocardial oxygenation; and 2) evaluate the diagnostic performance of BOLD imaging in the clinical setting.
METHODS: BOLD and first-pass perfusion images were acquired at rest and stress (4 to 5 min intravenous adenosine, 140 μg/kg/min) and assessed quantitatively (using a BOLD signal intensity index [stress/resting signal intensity], and absolute quantification of perfusion by model-independent deconvolution). A BOLD signal intensity index threshold to identify ischemic myocardium was first determined in a derivation arm (25 CAD patients and 20 healthy volunteers). To determine diagnostic performance, this was then applied in a separate group comprising 60 patients with suspected CAD referred for diagnostic angiography.
RESULTS: Prospective evaluation of BOLD imaging yielded an accuracy of 84%, a sensitivity of 92%, and a specificity of 72% for detecting myocardial ischemia and 86%, 92%, and 72%, respectively, for identifying significant coronary stenosis. Segment-based analysis revealed evidence of dissociation between oxygenation and perfusion (r = -0.26), with a weaker correlation of quantitative coronary angiography with myocardial oxygenation (r = -0.20) than with perfusion (r = -0.40; p = 0.005 for difference). Hypertension increased the odds of an abnormal BOLD response, but diabetes mellitus, hypercholesterolemia, and the presence of ventricular scar were not associated with significant deoxygenation.
CONCLUSIONS: BOLD imaging provides valuable insights into the pathophysiology of CAD; myocardial hypoperfusion is not necessarily commensurate with deoxygenation. In the clinical setting, BOLD imaging achieves favorable accuracy for identifying the anatomic and functional significance of CAD.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624835     DOI: 10.1016/j.jacc.2012.01.055

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

Review 1.  Cardiac imaging in patients with chronic kidney disease.

Authors:  Diana Y Y Chiu; Darren Green; Nik Abidin; Smeeta Sinha; Philip A Kalra
Journal:  Nat Rev Nephrol       Date:  2015-01-06       Impact factor: 28.314

Review 2.  Highlights of the year in JACC 2012.

Authors:  Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2013-01-22       Impact factor: 24.094

3.  Assessment of myocardial oxygenation with MRI.

Authors:  Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2013-04

4.  Free-breathing, motion-corrected, highly efficient whole heart T2 mapping at 3T with hybrid radial-cartesian trajectory.

Authors:  Hsin-Jung Yang; Behzad Sharif; Jianing Pang; Avinash Kali; Xiaoming Bi; Ivan Cokic; Debiao Li; Rohan Dharmakumar
Journal:  Magn Reson Med       Date:  2015-03-06       Impact factor: 4.668

Review 5.  Magnetic resonance imaging for characterizing myocardial diseases.

Authors:  Maythem Saeed; Hui Liu; Chang-Hong Liang; Mark W Wilson
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-31       Impact factor: 2.357

Review 6.  The Potential of Oxygenation-Sensitive CMR in Heart Failure.

Authors:  Elizabeth Hillier; Matthias G Friedrich
Journal:  Curr Heart Fail Rep       Date:  2021-08-11

Review 7.  Imaging the myocardial ischemic cascade.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David A Bluemke; Menko Jan de Boer; Jens Bremerich; Ernest V Garcia; Matthias Gutberlet; Pim van der Harst; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond Y Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Riemer H J A Slart; Vinod Thourani; Rozemarijn Vliegenthart; Bernd J Wintersperger
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

8.  Assessment of myocardial reactivity to controlled hypercapnia with free-breathing T2-prepared cardiac blood oxygen level-dependent MR imaging.

Authors:  Hsin-Jung Yang; Roya Yumul; Richard Tang; Ivan Cokic; Michael Klein; Avinash Kali; Olivia Sobczyk; Behzad Sharif; Jun Tang; Xiaoming Bi; Sotirios A Tsaftaris; Debiao Li; Antonio Hernandez Conte; Joseph A Fisher; Rohan Dharmakumar
Journal:  Radiology       Date:  2014-04-17       Impact factor: 11.105

9.  Feasibility of oxygen sensitive cardiac magnetic resonance of the right ventricle in pulmonary artery hypertension.

Authors:  Karthigesh Sree Raman; Michael Stokes; Angela Walls; Rebecca Perry; Peter M Steele; Christine Burdeniuk; Carmine G De Pasquale; David S Celermajer; Joseph B Selvanayagam
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

10.  Left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study.

Authors:  Karthigesh Sree Raman; Ranjit Shah; Michael Stokes; Angela Walls; Richard J Woodman; Rajiv Ananthakrishna; Jennifer G Walker; Susanna Proudman; Peter M Steele; Carmine G De Pasquale; David S Celermajer; Joseph B Selvanayagam
Journal:  Cardiovasc Diagn Ther       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.